Magis Shareholders Approve Strong 2025 Results and Reinvestment Plan

MAGIS S.p.A. ( (IT:MGS) ) has provided an update.

Magis S.p.A. reported 2025 revenues of €77.4 million, EBITDA of €8.6 million with an 11.1% margin, and net income of €3.15 million, all above its previously indicated guidance, underscoring the company’s resilience and strategic clarity in a challenging market environment. The company highlighted margin recovery in the fourth quarter, a net cash position of €7.49 million, shareholders’ equity of €45.19 million, and the launch of a new body care production line aimed at shifting its product mix toward higher value-added segments and supporting further margin expansion.

At the ordinary shareholders’ meeting, investors approved the 2025 financial statements and agreed to allocate the entire €3.15 million net income to the extraordinary reserve to finance a new investment cycle. Management signaled a positive start to 2026 with improving order trends and reiterated its strategy to deepen its presence in high value body care applications, a move that could strengthen Magis’s competitive positioning and support long-term growth despite ongoing macro uncertainty.

More about MAGIS S.p.A.

Magis S.p.A., based in Cerreto Guidi in Tuscany, is a leading producer of customized adhesive tapes and closure systems for body care products, including disposable diapers and adult incontinence items. Founded in 1983, it was an early innovator in hot-melt coating on polypropylene and protected printing, and it focuses on high-quality, highly customizable printing with strong attention to environmental sustainability.

Average Trading Volume: 2,117

Technical Sentiment Signal: Sell

Current Market Cap: €60.94M

See more data about MGS stock on TipRanks’ Stock Analysis page.